Slow-Flow Vascular Malformation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Slow-Flow Vascular Malformation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05983159

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

Recent studies have demonstrated that growth of vascular malformations can be driven by genetic variants in one of 2 signalling pathways. Targeted drugs specifi…

Australia50 participantsStarted 2024-09-13

Treatment: Alpelisib, Mirdametinib

All recent trials (3 shown)

CompletedPhase 2

NCT02509468

suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS

The most recent classification, adopted by International Society for the Study of Vascular Anomalies (ISSVA) in 1996, and updated in Melbourne in 2014, divides…

France63 participantsStarted 2015-09-30

Treatment: Sirolimus

UnknownNot Applicable

NCT02025101

Characterization of Slow Coronary Flow

Description of the phenomena "Slow Coronary Flow" (SCF), according to the data that has been collected from patients hospitalized with specific criteria. Clinic…

Israel90 participantsStarted 2014-01